<DOC>
	<DOCNO>NCT02707341</DOCNO>
	<brief_summary>The primary objective Corrona Psoriasis Registry study comparative safety approve psoriasis therapy national cohort psoriasis subject treat dermatologist . This include assess incidence nature adverse event special interest , include malignancy , real world population psoriasis patient new biologic therapy ( e.g . secukinumab ) . Secondary objective include analyze epidemiology natural history disease , comorbidities , current treatment practice , comparative effectiveness .</brief_summary>
	<brief_title>The Corrona Psoriasis Registry</brief_title>
	<detailed_description>Based operating procedure establish Corrona Rheumatoid Arthritis ( RA ) Registry , Psoriasis Registry use parallel structure base design strategy develop Corrona , LLC . This registry cooperatively manage scientific , operational , quality leader Corrona medical leader appoint National Psoriasis Foundation ( NPF ) . Investigators may enroll patient start switch systemic agent psoriasis within previous twelve month . Currently approve subcutaneous biologics indicate adult patient chronic moderate severe plaque psoriasis candidate systemic therapy phototherapy . The currently approve intravenous biologic agent indicate adult patient chronic severe plaque psoriasis candidate systemic therapy , systemic therapy medically less appropriate . All patient receive standard care treatment prescribe investigator , accordance FDA-approved drug labeling , treatment decision sole responsibility investigator . This study conduct approximately 200 site across United States . Sites assess select interview potential investigator correspond site feasibility survey include information investigator 's qualification , previous research experience , availability support staff , sub-investigators , patient population . The Corrona Psoriasis Registry longitudinal , observational study ; therefore , duration indefinite pre-determined stop date . The enrollment period estimate take approximately four year , subject follow minimum eight year begin time subject enrol . The design prospective , multicenter , observational registry subject psoriasis . Longitudinal follow-up data obtain via Corrona Questionnaires complete subject treat dermatologist ( also know `` Providers '' Corrona registry study ) every 6 month ( +/- 30 day ) . The registry design collect data patient demographic , smoke history , disease duration , disease severity , disease activity , history prior psoriasis treatment , comorbidities , hospitalization , adverse event special interest , medication use , laboratory result . The registry link external data source include Centers Disease Control 's National Death Index ( NDI ) , Centers Medicare Medicaid Services ( CMS ) , administrative data source support drug safety monitor research activity . Any adverse event spontaneously volunteer subject discover result general questioning investigator record Provider Follow-up Questionnaire visit .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>The subject psoriasis diagnose dermatologist The subject least 18 year age older The subject start switched systemic psoriasis treatment within previous 12 month . FDAapproved biologic treatment psoriasis nonbiologic treatment ( methotrexate , cyclosporine , apremilast ) allow . The subject unable unwilling provide inform consent participate registry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>psoriasis</keyword>
	<keyword>disease registry</keyword>
</DOC>